Spyre Therapeutics Inc (SYRE)

Financing Cash Flow

$432.60M

Quarterly · Period ending: · USD

SYRE logo

SYRE Financing Cash Flow

Latest reported$432.60M
SYRE Quarterly Cash from Financing ($0.00 → $432.60M)
High-resolution chart · PNG

SYRE financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
432,603,000
12,255,000
312,812,000
-4,643,000
731,000
125,000
225,601,000
12,780,000
360,000
172,165,000
163,606,000
-12,531,000
209,992,000
10,000
-8,000
-130,000
42,804,000
12,000
80,000
1,143,000
-192,000
362,000
24,679,000
258,000
129,293,000
282,000
676,000
311,000
-319,000
65,055,000
17,261,000
1,056,000
38,063,000
688,000
684,000
-118,000
11,551,000
96,000
0
76,000
49,392,000
-98,000
-203,000
-970,000
-831,000
43,678,000
0
5,575,000
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.